MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    12-month long-term outcomes of adaptive DBS using LFP sensing technology

    K. Kimura, H. Kishida, T. Kawasaki, N. Ueda, F. Tanaka (Yokohama, Japan)

    Objective: The aim of this study was to clarify the 12-month long-term outcome of Parkinson’s disease (PD) patients receiving adaptive DBS therapy. Background: During the…
  • 2024 International Congress

    The study of evaluating the impact of simulating indoor environments using virtual reality on gait in Parkinson’s Disease

    K. Seo, S. Emoto, K. Abe, T. Ishii, M. Miki, M. Hara, T. Yamamoto (Saitama, Japan)

    Objective: This study aims to quantitatively assess how indoor environments affect on gait disturbances in PD patients using virtual reality (VR). Background: Patients with Parkinson's…
  • 2024 International Congress

    A non-linear index can detect early postural instability in people with Parkinson’s disease: Enhancing perspectives on the utilization of cost-effective technologies.

    G. Santos, M. D'Alencar, A. Frazão, A. Roque, J. Vivas, M. Piemonte (São Paulo, Brazil)

    Objective: To investigate the effectiveness of a non-linear index for identifying the decline in postural control associated with PD progression. Background: Postural instability is a…
  • 2024 International Congress

    eHealth – an Opportunity for personalized Care? – Healthcare Professionals’ Technology Acceptance in the Care of Parkinson’s Patients

    J. Stuempel, J. Hohn, V. Fleckenstein, K. Steidel, C. Münte, D. Pedrosa (Marburg, Germany)

    Objective: To examine how eHealth may improve personalized care for people with Parkinson's disease (PwPD) from the perspective of healthcare professionals (HCPs). Background: Parkinson's disease…
  • 2024 International Congress

    Is essential tremor-plus phenotype a prodromal phase of Parkinson’s disease ?

    A. Rekik, A. Mili, H. Slimene, K. Jemai, E. Jarrar, A. Hassine, S. Naija, S. Ben Amor (Sousse, Tunisia)

    Objective: To study the probability of conversion of essential tremor (ET) and ET-plus patients to Parkinson's disease (PD). Background: ET-plus syndrome represents a wide spectrum…
  • 2024 International Congress

    The Genetic Landscape of Parkinson’s Disease in an Italian Cohort and the Need for a Standardized Approach

    AT. Cimmino, P. Sanginario, F. Musso, D. Genovese, A. de Biase, M. Petracca, F. Bove, C. Piano, FD. Tiziano, AR. Bentivoglio, P. Calabresi, G. Di Lazzaro (Rome, Italy)

    Objective: Our study aimed to identify the genetic determinants and their prevalence in an Italian cohort of Parkinson’s disease (PD) patients. Background: Advances in genetics…
  • 2024 International Congress

    Utilizing a global network to study environmental factors relating to Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2)

    K. Atterling Brolin, L. Jones, B. Fiske, S. Jasaityte, H. Morris, A. Noyce (Lund, Sweden)

    Objective: To identify and collect data on non-genetic variables from individuals with and without Parkinson’s disease (PD) in the Global Parkinson’s Genetics Program (GP2, http://gp2.org/).…
  • 2024 International Congress

    Artificial intelligence: a potential predictor of GBA1-mutated genotype in Parkinson’s Disease patients?

    G. Di Rauso, A. Ghibellini, S. Grisanti, F. Cavallieri, V. Fioravanti, E. Monfrini, G. Toschi, G. Portaro, J. Rossi, R. Sabadini, L. Gherardini, C. Lucchi, G. Biagini, L. Bononi, M. Gabbrielli, A. Di Fonzo, F. Valzania (Reggio Emilia, Italy)

    Objective: To assess whether artificial intelligence could predict GBA1-mutated genotype in Parkinson’s Disease (GBA1-PD) patients according to the different impact of significant clinical features. Background:…
  • 2024 International Congress

    Frequency of Variants of Uncertain Significance in a Cohort of Early-onset Parkinson’s Disease Patients

    A. Zare Dehnavi, C. Piat, N. Niu, O. Ross, A. de Menezes, P. Gaia, R. Savica (Rochester, USA)

    Objective: Aim of the study is to report the frequency of variants of uncertain significance (VUS) in a cohort of patients with early-onset Parkinson’s disease…
  • 2024 International Congress

    Fatigue in PD is related to decreased efficiency of the frontal network

    SY. Kang, MS. Kim, S. Park, U. Park, SW. Kang (Hwaseong, Republic of Korea)

    Objective: We aimed to explore whether electroencephalography (EEG) could measure fatigue objectively and the pathophysiology of fatigue in PD. Background: Fatigue is a common, frustrating…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley